Exclusive Summary

• Offers both 60mg (OTC) and 120mg (Rx) dosages concurrently, empowering distributors to achieve full-channel coverage across both retail and clinical markets.
• With all originator patents long expired, leveraging the large-scale manufacturing advantages of China's supply chain delivers highly competitive pricing and maximizes distributor margins.
• Addressing the soaring demand from over 1 billion obese individuals globally, it stands as the only OTC-approved, non-systemic weight-loss drug with proven safety and mature market acceptance.
• Supported by stringent international GMP compliance and ready-to-submit CTD dossiers, significantly shortening local registration timelines for rapid market entry.